A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity ...

A retrospective study demonstrated slightly elevated baseline fasting plasma glucose levels to be a robust marker of incident diabetes risk, even when those levels fell within the normal range.

The reason is unclear but experts say those with the condition often engage in unhealthy habits and struggle to access health care.

Hemak, president and CEO of the Wright Centers for Community Health and Graduate Medical Education, was named one of the 100 most powerful and influential female leaders in ...

A report from The Lancet Diabetes & Endocrinology Commission has proposed new criteria for defining and diagnosing obesity, ...

The short answer is yes, PCOS has a complex genetic predisposition. However, lifestyle and environmental factors also play a ...

It lowers blood pressure and cholesterol and  sends 'fullness' signals to the brain, like a weight-loss drug. Here are simple ...

Leading health experts challenge traditional BMI measurements and introduce a comprehensive new approach to diagnosing obesity, potentially affecting millions.

Fatty liver disease, or hepatic steatosis, occurs when excess fat accumulates in liver cells. Commonly associated with ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...